Short answer
Niagen Bioscience, Inc. (NAGE) filed an 8-K current report with the SEC on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2). Q3 fiscal 2026 earnings announcement for quarter ended September 30, 2026.
Niagen Bioscience, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 fiscal 2026 earnings announcement for quarter ended September 30, 2026
- Exhibit 99.1 contains Niagen Bioscience’s detailed financial results and management commentary
Item 7.01 · Regulation FD Disclosure
- Corporate presentation released November 4, 2026, providing updated company information to investors
- Exhibit 99.2 contains the presentation, including potentially material business and strategic updates
Item EX-99.1 · Exhibit EX-99.1
- Q3 net sales $27.2M, down from $34.0M; Tru Niagen contributed $23.3M
- Gross margin 62.9%, while net loss reached $1.2M versus $4.6M net income last year
- Adjusted EBITDA remained positive at $0.5M, but declined from $6.4M in Q3 2025
- Cash $69.5M and operating cash flow $2.6M supported continued investment without disclosed borrowing
- Product expansion includes at-home injections, skincare, Walmart.com, and nearly 300 GNC and Sam’s Club locations
Item EX-99.2 · Exhibit EX-99.2
- Q3 2026 earnings presentation: net sales $27.2M, down 20% year over year, with Tru Niagen sales $23.3M
- Profitability weakened: gross margin 62.9% versus 64.5%, net loss $(1.2)M, and Adjusted EBITDA $0.5M versus $6.4M
- Core direct-to-consumer sales grew 13% year over year, while 2026 guidance targets 15-20% direct website growth
- Liquidity remained strong: $69.5M cash, no borrowings, and $2.6M operating cash flow
- Growth investment expanded through Niagen Plus injections, NanoCloud skincare, Walmart and GNC launches, and NB4168 development
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Niagen Bioscience, Inc. 8-K filings
Get the next NAGE 8-K as it lands
Follow NAGE for push alerts, or ask the research agent what this filing means.